Steward Partners Investment Advisory, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$9,0000.0%1000.0%0.00%
Q2 2022$9,000
+125.0%
100
+185.7%
0.00%
Q1 2022$4,000
-96.3%
35
-95.0%
0.00%
-100.0%
Q4 2021$108,000
+12.5%
702
+2.3%
0.00%0.0%
Q3 2021$96,000
+20.0%
686
+12.8%
0.00%
+100.0%
Q2 2021$80,000
-99.9%
608
+29.4%
0.00%0.0%
Q1 2021$71,652,000
+597000.0%
470
+295.0%
0.00%
Q4 2020$12,000
+9.1%
1190.0%0.00%
Q3 2020$11,000
-15.4%
1190.0%0.00%
Q2 2020$13,000
+62.5%
1190.0%0.00%
Q1 2020$8,000
-33.3%
119
-0.8%
0.00%
Q4 2019$12,000
+9.1%
120
+0.8%
0.00%
Q3 2019$11,000
+22.2%
119
+41.7%
0.00%
Q2 2019$9,000
-77.5%
84
-41.7%
0.00%
-100.0%
Q3 2018$40,000
+135.3%
144
+71.4%
0.00%
+100.0%
Q2 2018$17,000
+30.8%
840.0%0.00%0.0%
Q1 2018$13,000
+333.3%
84
+180.0%
0.00%
Q2 2017$3,000
+50.0%
30
+20.0%
0.00%
Q1 2017$2,000250.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders